101 related articles for article (PubMed ID: 16637233)
1. Ameliorating effect of dimethylsulfoniopropionate on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease of mice.
Nakajima K; Minematsu M
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):70-4. PubMed ID: 16637233
[TBL] [Abstract][Full Text] [Related]
2. Significant effect of dimethylsulfoniopropionate on Parkinson's disease of senescence-accelerated mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Minematsu M; Nakajima K
J Nutr Sci Vitaminol (Tokyo); 2008 Aug; 54(4):335-8. PubMed ID: 18797157
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease model.
Hong MS; Park HK; Yang JS; Park HJ; Kim ST; Kim SN; Park JY; Song JY; Park HK; Jo DJ; Park SW; HwanYun D; Ban JY; Chung JH
Neurol Res; 2010 Feb; 32 Suppl 1():74-8. PubMed ID: 20034450
[TBL] [Abstract][Full Text] [Related]
4. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Nishi K; Kondo T; Narabayashi H
No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the outgrowth and elongation of neurites from pheochromocytoma cells by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and preventive effects of dimethylsulfoniopropionate in the presence of nerve growth factor.
Nakajima K; Minematsu M; Miyamoto Y
J Nutr Sci Vitaminol (Tokyo); 2008 Apr; 54(2):176-80. PubMed ID: 18490849
[TBL] [Abstract][Full Text] [Related]
6. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
[TBL] [Abstract][Full Text] [Related]
7. Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Al-Sweidi S; Morissette M; Di Paolo T
J Neuroendocrinol; 2012 Nov; 24(11):1375-85. PubMed ID: 22672467
[TBL] [Abstract][Full Text] [Related]
8. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
[TBL] [Abstract][Full Text] [Related]
9. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
[TBL] [Abstract][Full Text] [Related]
10. A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease.
Liebetanz D; Baier PC; Paulus W; Meuer K; Bähr M; Weishaupt JH
Exp Neurol; 2007 May; 205(1):207-13. PubMed ID: 17341420
[TBL] [Abstract][Full Text] [Related]
11. MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.
Zhu G; Li J; He L; Wang X; Hong X
Br J Pharmacol; 2015 May; 172(9):2354-68. PubMed ID: 25560396
[TBL] [Abstract][Full Text] [Related]
12. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of a tertiary sulfonium compound, dimethylsulfoniopropionate, in green sea algae on Ehrlich ascites carcinoma-bearing mice.
Nakajima K; Yokoyama A; Nakajima Y
J Nutr Sci Vitaminol (Tokyo); 2009; 55(5):434-8. PubMed ID: 19926931
[TBL] [Abstract][Full Text] [Related]
14. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
Alam G; Edler M; Burchfield S; Richardson JR
Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
[TBL] [Abstract][Full Text] [Related]
15. Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.
Zhao TT; Kim KS; Shin KS; Park HJ; Kim HJ; Lee KE; Lee MK
BMC Complement Altern Med; 2017 Sep; 17(1):449. PubMed ID: 28877690
[TBL] [Abstract][Full Text] [Related]
16. Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Fuller RW; Hahn RA; Snoddy HD; Wikel JH
Biochem Pharmacol; 1984 Oct; 33(19):2957-60. PubMed ID: 6333240
[TBL] [Abstract][Full Text] [Related]
17. Reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced parkinsonism.
Fukumitsu N; Suzuki M; Fukuda T; Kiyono Y; Kajiyama S; Saji H
Nucl Med Biol; 2006 Jan; 33(1):37-42. PubMed ID: 16459257
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?
Allen JM; Cross AJ; Yeats JC; Ghatei MA; McGregor GP; Close SP; Pay S; Marriott AS; Tyers MB; Crow TJ
Brain; 1986 Feb; 109 ( Pt 1)():143-57. PubMed ID: 2417654
[TBL] [Abstract][Full Text] [Related]
19. Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
Castro AA; Ghisoni K; Latini A; Quevedo J; Tasca CI; Prediger RD
Behav Brain Res; 2012 Apr; 229(1):208-15. PubMed ID: 22266923
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease.
Oyagi A; Oida Y; Hara H; Izuta H; Shimazawa M; Matsunaga N; Adachi T; Hara H
Brain Res; 2008 Jun; 1214():169-76. PubMed ID: 18457816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]